These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 9381270

  • 1. [Prenatal diagnosis and current status of the prevention of feto-maternal isoimmunization by anti-D].
    Martín Vega C.
    Sangre (Barc); 1997 Jun; 42(3):239-41. PubMed ID: 9381270
    [No Abstract] [Full Text] [Related]

  • 2. Fetal RhD genotyping: a more efficient use of anti-D immunoglobulin.
    Daniels G, Finning K, Martin P, Summers J.
    Transfus Clin Biol; 2007 Dec; 14(6):568-71. PubMed ID: 18436463
    [Abstract] [Full Text] [Related]

  • 3. [Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].
    Cortey A, Brossard Y.
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S123-1S130. PubMed ID: 16495838
    [Abstract] [Full Text] [Related]

  • 4. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E, Cavelier B, Bonneau JC, Rouger P.
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [Abstract] [Full Text] [Related]

  • 5. [Prevention of fetomaternal rhesus-D allo-immunization. Perspectives].
    Cortey A, Brossard Y, Beliard R, Bourel D.
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S119-1S122. PubMed ID: 16495837
    [Abstract] [Full Text] [Related]

  • 6. Detection of fetomaternal hemorrhage.
    Kim YA, Makar RS.
    Am J Hematol; 2012 Apr; 87(4):417-23. PubMed ID: 22231030
    [Abstract] [Full Text] [Related]

  • 7. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM.
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract] [Full Text] [Related]

  • 8. [Current status of neonatal hemolytic disease caused by Rh incompatibility].
    Uhlig R, Menzel K.
    Z Arztl Fortbild (Jena); 1986 Sep; 80(4):143-8. PubMed ID: 3087070
    [No Abstract] [Full Text] [Related]

  • 9. Fifteen years' experience with post-partum Rh prophylaxis in Norway (1969-83): incidence of new cases of anti-D and other clinically important blood group antibodies in pregnant women.
    Kornstad L.
    NIPH Ann; 1987 Jun; 10(1):3-10. PubMed ID: 3116469
    [Abstract] [Full Text] [Related]

  • 10. [Fetal RHD genotyping by PCR using plasma from D negative pregnant women].
    Achargui S, Tijane M, Benchemsi N.
    Transfus Clin Biol; 2011 Feb; 18(1):13-9. PubMed ID: 21190884
    [Abstract] [Full Text] [Related]

  • 11. Haemolytic disease of the newborn: the new NICE guidelines.
    Thompson J.
    J Fam Health Care; 2002 Feb; 12(5):133-6. PubMed ID: 12449064
    [Abstract] [Full Text] [Related]

  • 12. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible.
    Müller SP, Bartels I, Stein W, Emons G, Gutensohn K, Köhler M, Legler TJ.
    Transfusion; 2008 Nov; 48(11):2292-301. PubMed ID: 18694461
    [Abstract] [Full Text] [Related]

  • 13. [Prenatal immunoglobulin prevention in Rh(D)-negative nonsensitized pregnant women].
    Katsulov A.
    Akush Ginekol (Sofiia); 1997 Nov; 36(2):1-2. PubMed ID: 9471891
    [No Abstract] [Full Text] [Related]

  • 14. Do we need to be more concerned about weak D antigens?
    Garratty G.
    Transfusion; 2005 Oct; 45(10):1547-51. PubMed ID: 16181202
    [No Abstract] [Full Text] [Related]

  • 15. Immunoprophylaxis for rhesus disease--expensive but worth it?
    Selinger M.
    Br J Obstet Gynaecol; 1991 Jun; 98(6):509-12. PubMed ID: 1908313
    [No Abstract] [Full Text] [Related]

  • 16. [Recommendations for clinical practice. Prevention in maternofetal Rh immunization (December 2005)].
    Collège National des Gynécologues et Obstétriciens Français.
    Gynecol Obstet Fertil; 2006 Apr; 34(4):360-5. PubMed ID: 16644259
    [No Abstract] [Full Text] [Related]

  • 17. [Social Welfare Board's recommendations for preventive treatment in the origin of Rh immunization].
    Högman C, Nilsson BA.
    Jordemodern; 1987 Oct; 100(10):321-4. PubMed ID: 2826372
    [No Abstract] [Full Text] [Related]

  • 18. [Management of feto-maternal red cell allo-immunizations].
    Bricca P, Guinchard E, Guitton Bliem C.
    Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
    [Abstract] [Full Text] [Related]

  • 19. RhD hemolytic disease of the newborn.
    Bowman JM.
    N Engl J Med; 1998 Dec 10; 339(24):1775-7. PubMed ID: 9845715
    [No Abstract] [Full Text] [Related]

  • 20. [Clinical aspects of prenatal prevention of rhesus incompatibility].
    Maas DH.
    Beitr Infusionsther; 1992 Dec 10; 30():425-30. PubMed ID: 1284752
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.